EQUINE HERPESVIRUS-1 MOLECULAR PREVALENCE AND SEROLOGICAL STATUS OF HEALTHY BROODMARES IN SOUTHERN ONTARIO
Authors:
- Carina J. CooperCCCarina J. Cooper
- Gisela Soboll HusseyGisela Soboll Hussey
- Jutta D. HammermuellerJHJutta D. Hammermueller
- David L. PearlDPDavid L. Pearl
- Luis G. ArroyoLALuis G. Arroyo
- Brandon N. LillieBLBrandon N. Lillie
Preprint
- 23 September 2026
- preprint
- Published by Elsevier in SSRN Electronic Journal
Abstract
Equine herpesvirus-1 is associated with abortion, respiratory disease and myeloencephalopathy. Vaccination is used to mitigate diseases and limit virus spread, but the serological status of Ontario’s broodmare population or the response to vaccination is unknown. We hypothesize that broodmares have a high anti-EHV-1 titres due to vaccination and exposure, but titres are not affected by pregnancy status. Sera were collected from 381 healthy broodmares from 42 Ontario farms bi-monthly from December 2016 through October 2017. Blood, nasal, and vaginal swab samples for EHV-1 droplet digital PCR analysis were also collected every two months, as well as demographic surveys and vaccination information. Serology was assessed using virus neutralization and ELISA for IgGa (IgG1), IgGb (IgG4/7), and IgG(T) (IgG3/5). Titers significantly varied by breed/breed group, but differences varied by serological measure. Titers increased with age but were not affected by pregnancy status. Most mares had EHV-1 specific IgG and virus neutralizing (VN) titers but 32.3% did have neutralizing titers < 1:512, and 42.1 % of vaccinated mares had no biologically significant changes in their neutralizing titers during the study period. IgG subisotype levels varied with the vaccine product, but not in a consistent pattern across subisotypes. No IgG subisotype was significantly associated with EHV-1 detection. Vaccination was associated with increased titers regardless of type of vaccine used, no vaccine product produced a consistent immune response and a fraction of mares did not respond to commercial vaccines despite regular vaccination, and titer levels were not predictive of EHV-1 detection.Keywords
This publication has 29 references indexed in Scilit:
- Antibody and cellular immune responses of naïve mares to repeated vaccination with an inactivated equine herpesvirus vaccineVaccine, 2015
- Genetics of anti-EHV antibody responses in a horse populationResearch in Veterinary Science, 2013
- Control of EHV-1 viremia and nasal shedding by commercial vaccinesVaccine, 2010
- Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of poniesVeterinary Immunology and Immunopathology, 2006
- Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanusVeterinary Immunology and Immunopathology, 2006
- Detection of equine herpesvirus-specific effector and memory cytotoxic immunity in the equine upper respiratory tractVeterinary Immunology and Immunopathology, 2006
- Detection of equine herpesvirus type 1 using a real-time polymerase chain reactionJournal of Virological Methods, 2006
- Polymorphisms in equine immune response genes and their associations with infectionsMammalian Genome, 2004
- Monoclonal antibodies specific for equine IgG sub-isotypes including an antibody which recognizes B lymphocytesVeterinary Immunology and Immunopathology, 1995
- Experimental immunization against respiratory disease due to equid herpesvirus 1 infection (rhinopneumonitis) using formalin-inactivated virus with various adjuvantsVeterinary Microbiology, 1979